Notice of Updated or Retired Clinical Policies
June 12, 2026
WellCare of Kentucky is updating and/or retiring some clinical policies effective July 12, 2026.
The table below details the changes. View these updates & more on the Kentucky Providers CCG page.
| Policy Number | Policy Title | Revision Date |
|---|---|---|
| UPDATED | ||
| 2025.2 | Concert Genetic Testing: CG Multisystem Genetic Conditions | 1/31/2026 |
| CP.MP.102 | Pancreas Transplant | 1/31/2026 |
| CP.MP.141 | Nonmyeloablative Allogeneic Stem Cell Transplants | 1/31/2026 |
| CP.MP.162 | Tandem Transplant | 1/31/2026 |
| CP.MP.252 | Immobilized Lipase Cartridges | 2/28/2026 |
| CP.MP.132 | Heart-Lung Transplant | 2/28/2026 |
| CP.MP.246 | Pediatric Kidney Transplant | 2/28/2026 |
| CP.MP.57 | Lung Transplantation | 2/28/2026 |
| CP.BH.105 | ABA Documentation Policy | 2/28/2026 |
| CP.BH.104 | Applied Behavior Analysis | 2/28/2026 |
| CP.BH.201 | Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder | 2/28/2026 |
| V2.2025 | Concert Genetic Testing: Prenatal Diagnosis | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Testing Oncology: Cancer Screening and Surveillance | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: General Approach to Genetic and Molecular Testing | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Identity and Forensics | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Immunology and Rheumatology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing Oncology: Hematologic Malignancy | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Hereditary Cancer | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Preimplantation Genetic Testing | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Prenatal and Preconception Carrier Screening | 11/30/2025 |
| V2.2025 | Concert Genetic Testing Oncology: Solid Tumor Molecular Diagnostics | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Nephrology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Neurology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Nutrition and Metabolism | 11/30/2025 |
| V2.2025 | Concert Genetic Testing Oncology: Algorithmic Assays | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Ophthalmology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Cardiovascular | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Dermatology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Endocrinology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Gastroenterology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Hematology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Otolaryngology | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Prenatal Screening | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Orthopedics | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Respiratory | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Toxicology and Pharmcogenetics Version B | 11/30/2025 |
| V2.2025 | Concert Genetic Testing: Transplant | 11/30/2025 |
| RETIRED | ||
| CP.MP.69 | Intensity-Modulated Radiotherapy | |
| CP.MP.53 | Ferriscan R2- MRI | |
| CP.MP.92 | Acupuncture | |
| CP.MP.71 | Long Term Care Placement | |
Thank you for your continued partnership in delivering quality healthcare to our members. If you have any questions regarding this notice, please contact your Provider Relations Representative.